NCT04178707

Brief Summary

Anal Fistula can be a challenging condition to treat. Microdialysis has never before been used to examine the inner environment of anal fistula. This is now going to be performed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 26, 2019

Completed
14 days until next milestone

Study Start

First participant enrolled

December 10, 2019

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2024

Completed
Last Updated

December 13, 2022

Status Verified

December 1, 2022

Enrollment Period

4 years

First QC Date

October 25, 2019

Last Update Submit

December 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • measurements of glucose in anal fistula using microdialysis

    measurements of glucose in fistula using microdialysis, change in value is being assessed

    baseline measurement, 1 month follow up

Secondary Outcomes (1)

  • measurement of pyruvate in anal fistula using microdialysis

    baseline measurement, 1 month follow up

Other Outcomes (1)

  • measurement of lactate in anal fistula using microdialysis

    baseline measurement, 1 month follow up

Study Arms (1)

Intervention

OTHER

Using microdialysis the patients inner enviorment of the anal fistula will be measured - levels of lactate, glucose and pyruvate.

Device: OnZurf Probe, Senzime AB, Uppsala, Sweden

Interventions

Probe is inserted into the fistula and measurements are made of the inner environment.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • over 18 years of age
  • to be able to understand and accept the terms of study

You may not qualify if:

  • age under 18
  • dementia, language barrier

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umea University Hospital

Umeå, Västerbotten County, 90381, Sweden

RECRUITING

MeSH Terms

Conditions

Rectal Fistula

Condition Hierarchy (Ancestors)

Intestinal FistulaDigestive System FistulaDigestive System DiseasesIntestinal DiseasesGastrointestinal DiseasesRectal DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Ulf Gunnarsson, Professor

    University Hospital, Umeå

    STUDY CHAIR

Central Study Contacts

Karin Strigard, Associate Professor

CONTACT

Karin Adamo, PhD student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Microdialysis is used to investigate the inner enviorment of anal fistulas. The patient will be its own control with measurements at prior to intervention and after operative procedure.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Principal Investigator

Study Record Dates

First Submitted

October 25, 2019

First Posted

November 26, 2019

Study Start

December 10, 2019

Primary Completion

November 30, 2023

Study Completion

December 20, 2024

Last Updated

December 13, 2022

Record last verified: 2022-12

Locations